share_log

Needham Reiterates Buy on Inari Medical, Maintains $72 Price Target

Benzinga ·  Mar 6 07:46

Needham analyst Mike Matson reiterates Inari Medical (NASDAQ:NARI) with a Buy and maintains $72 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment